Global Pet In Vitro Diagnostics Market Growth (Status and Outlook) 2025-2031

The global Pet In Vitro Diagnostics market size is predicted to grow from US$ 50150 million in 2025 to US$ 103650 million in 2031; it is expected to grow at a CAGR of 12.9% from 2025 to 2031.

The diagnosis of pets can also be divided into biochemical diagnosis, immune diagnosis, molecular diagnosis, blood diagnosis, etc.

United States market for Pet In Vitro Diagnostics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Pet In Vitro Diagnostics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Pet In Vitro Diagnostics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Pet In Vitro Diagnostics players cover IDEXX, Mars（Antech）, Zoetis, Heska, Covetrus (Henry Schein), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Pet In Vitro Diagnostics Industry Forecast” looks at past sales and reviews total world Pet In Vitro Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Pet In Vitro Diagnostics sales for 2025 through 2031. With Pet In Vitro Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet In Vitro Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Pet In Vitro Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pet In Vitro Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pet In Vitro Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet In Vitro Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet In Vitro Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of Pet In Vitro Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:
Immunodiagnostics
Clinical Biochemical Molecular Diagnosis
Blood Diagnosis
Other

Segmentation by Application:
Pet Hospital
Household
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
IDEXX
Mars（Antech）
Zoetis
Heska
Covetrus (Henry Schein)
Johnson
Siemens
Midmark Corporation
Smiths Medical
Olympus
Carestream Health
GE Healthcare
Nonin Medical
Mindray
Yuesen Med
DBC-Healthcare
APK Image
Shinova Medical Co.,Ltd.
Abaxis
Wondfo

Please note: The report will take approximately 2 business days to prepare and deliver.